Quanterix Corporation (QTRX) earnings

QTRX earnings moved a median of +0.90% by the close. Quarterly and annual QTRX reports and results, each read against the price at its own news timestamp. Back to the QTRX overview →

29 measured QTRX earnings events.

Where these QTRX earnings landedvs 28 measured QTRX earnings reactions
QTRX earningsMiddle 50% · -2.26% to +5.79%Zero: 0.00%Median: +0.90%Median +0.90%-8.00%0+8.00%
Middle 50% of QTRX earnings reactions-2.26% to +5.79%
Median reaction (to close)+0.90%
Measured reactions28
Point-in-time · zero look-ahead

Half of the 28 QTRX earnings events with a measured close landed between -2.26% and +5.79%; 54% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Quanterix Corp For: Jun 30SEC filing · Form 10-Q-0.86%—
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026Press release+1.47%-1.07%
Form 10-Q Quanterix Corp For: Mar 31SEC filing · Form 10-Q-8.57%-12.70%
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026Press release-0.79%+3.15%
Form 10-K Quanterix Corp For: Dec 31SEC filing · Form 10-K+9.28%+2.80%
Form 10-Q Quanterix Corp For: Sep 30SEC filing · Form 10-Q-5.87%+1.22%
Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025Press release+1.12%-0.94%
Form 10-Q Quanterix Corp For: Jun 30SEC filing · Form 10-Q-7.74%-3.26%
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025Press release-0.74%-2.46%
Form 10-Q Quanterix Corp For: Mar 31SEC filing · Form 10-Q-6.78%-19.30%
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025Press release+0.15%-2.19%
Form 10-K/A Quanterix Corp For: Dec 31SEC filing · Form 10-K-3.31%+0.00%
Form 10-K Quanterix Corp For: Dec 31SEC filing · Form 10-K+0.60%+7.36%
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings CallPress release+0.60%+7.36%
Form 10-K/A Quanterix Corp For: Dec 31SEC filing · Form 10-K+0.29%+5.93%
Form 10-Q Quanterix Corp For: Sep 30SEC filing · Form 10-Q+0.29%+5.93%
Form 10-Q/A Quanterix Corp For: Jun 30SEC filing · Form 10-Q+0.29%+5.93%
Form 10-Q/A Quanterix Corp For: Mar 31SEC filing · Form 10-Q+0.29%+5.93%
Form NT 10-Q Quanterix Corp For: Sep 30SEC filing · Form NT-0.48%-3.95%
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024Press release+1.20%+2.74%
Form 10-Q Quanterix Corp For: Jun 30SEC filing · Form 10-Q+4.49%-1.35%
Quanterix To Report Second Quarter 2024 Financial ResultsPress release+1.29%-4.75%
Form 10-Q Quanterix Corp For: Mar 31SEC filing · Form 10-Q+0.19%+3.71%
Quanterix To Report First Quarter 2024 Financial ResultsPress release-0.97%+4.20%
Form 10-K Quanterix Corp For: Dec 31SEC filing · Form 10-K+10.59%+17.70%
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidancePress release-5.49%-3.94%
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallPress release-0.30%+0.58%
Form 10-Q Quanterix Corp For: Sep 30SEC filing · Form 10-Q-2.37%-2.17%
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023Press release+0.00%+5.75%
That’s how QTRX usually reacts to earnings — get an email when it moves on news →
Keep exploring

More QTRX: analyst actions → · SEC filings → · QTRX overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Inovio Pharmaceuticals, Inc. (INO)658-0.29%43%
VistaGen Therapeutics, Inc. (VTGN)658+0.16%52%
Encompass Health Corporation (EHC)656+0.01%51%
DIPLOMAT PHARMACY INC (DPLO)6540.00%50%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.